SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers

NCT07080619 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

TNBC - Triple-Negative Breast Cancer
HR+ Breast Cancer

Interventions

DRUG: SC-101

Sponsor

Tianjin ConjuStar Biologics Co., Ltd.